# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Neutral and maintains ...
Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0....
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Asensus Surgical (AMEX:ASXC) from Buy to Neutral and lower...
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical (AMEX:ASXC) with a Buy and maintains $2 pr...